Skip to main content

Treatment for Waldenstrom’s macroglobulinaemia (WM)

Treatment
With regular check-ups, active monitoring and treatment regimes, many people with Waldenstrom's macroglobulinaemia live with the disease for years. Here, you can find out what treatments might be available to you, and what to expect.

A team of specialists (a multi-disciplinary team or MDT) will meet to discuss your treatment, and your doctor or nurse will discuss and explain the options available to you.

Some people do not need any treatment when they are first diagnosed. WM usually develops slowly, the term to describe this gradual behaviour is 'indolent'. This means some people may not need treatment for many months, often years. During this time you will have regular check-ups in the outpatients clinic. This active monitoring is known as being on 'watch and wait' or 'watchful waiting'.

Watch and wait

If your doctor decides no treatment is needed you will have regular check-ups, to assess how you are feeling and to take blood tests to measure your blood cell counts and IgM levels. This kind of follow-up, with check-ups but without treatment, is quite common in people with WM. If you have no symptoms you will typically be seen in the clinic every 3-6 months for review.

Watch and wait may feel difficult but can often be the best treatment for WM initially. There is no evidence that starting treatment early is advantageous. It can be hard to wait for symptoms to develop or for things to get worse before anything is done. It can make you feel anxious and unable to enjoy the relative good health you have. If this happens, it is important to talk about this with your doctor, specialist nurse and family and friends as there is support available, including psychological support.

Read more about living with WM here

Find support here

When treatment starts

At the moment, there isn't a cure for WM. Instead, your treatment for Waldenstrom's macroglobulinaemia is aimed at improving your quality of life and keeping you well for as long as possible, with the least possible side effects.

Your treatment may start if:

  • You begin to get symptoms that are due to your WM
  • The level of IgM protein in your blood is increasing at a rapid rate or you experience hyperviscosity (thickening of the blood)
  • Your blood count changes - for example, you develop anaemia (low levels of red blood cells)
  • You develop other complications, such as a progressive neuropathy, cryoglobulinaemia or Cold Agglutinin Disease, that is felt to be due to the effects of the abnormal IgM levels.

The treatment you have will depend on your personal situation. Your medical team will assess you based on:

  • The results of all your tests.
  • Your symptoms - for example, how severe they are and whether you have neuropathy.
  • Your age and general health.

There are a range of treatments available for WM. The main treatment has for many years been chemotherapy. However, as a result of research and clinical trials, many new therapies are becoming available to treat WM patients, often known as 'biological treatments'.

Chemotherapy

Chemotherapy (chemo) is the use of anti-cancer drugs to destroy cancer cells. It can be given as tablets, into a vein, or as an injection under the skin.

Read more about chemotherapy

Steroids

Steroids are often used as part of the treatment as they can help the other drugs to destroy the abnormal B-cells and make chemotherapy more effective.

Read more about steroids

Monoclonal antibody therapy

Monoclonal antibodies are drugs that recognise, target and stick to particular proteins on the surface of cancer cells. They can stimulate the body’s own immune system to destroy these cells.

Read more about monoclonal therapy

Common treatment regimes

Most patients with symptomatic WM will received a combination of rituximab (a biological therapy), plus chemotherapy. The exact choice of regimen depends on multiple factors, including the level of bone marrow involvement, whether there is hyperviscosity or neuropathy, the age and fitness of the patient, and if autologous stem cell transplantation is planned.

Read more about common treatment regimes

Biological treatments

A great deal of international collaboration and effort in recent years means that there are new therapies becoming available for patients with WM. This includes treatments which target chemical pathways within the lymphoplasmacytic (LPL) cells and also affect the way LPL cells work with their environment (in this case, the bone marrow).

Other biological treatments include ‘immunomodulatory’ drugs which modify the function of the immune system, such as thalidomide.

Read more about biological treatments

Stem cell transplantation

Some people with WM may have treatment involving the use of their own stem cells, or stem cells from a donor.

Read more about stem cell transplantation

CAR T-cell therapy (chimeric antigen receptor T-cell therapy)

This is a treatment in which a patient's T-cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.

Read more about CAR T-cell therapy

Supportive treatments

Supportive treatments are designed to counteract some of the symptoms of the lymphoma and the side effects of the treatments. In WM, these supportive treatments include antibiotics that are given to prevent infections (which may occur during chemotherapy cycles), blood transfusions and plasma exchange.

Read more about supportive treatments

Clinical trials for Waldenstrom's macroglobulinaemia

Clinical trials are research studies that test new medical treatments and you may be asked if you would like to take part in one. Clinical trials are very important in improving future treatments for people with WM and also provide you with a chance to access new treatments that aren’t available elsewhere.

Read more about clinical trials in the UK

Have questions? We're here to help you - call or email us for support and information.

 

Agile Social Share

Share this page